ELVN- Enliven Therapeutics, Inc.

Name: Enliven Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Enliven Therapeutics, Inc. (ELVN) has 10 insiders with recent SEC Form 4 filings, including 11 buys and 17 sells. ELVN is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Kintz Samuel	890.4K	$40.92M	-
CEO	Fair Richard A.	875.0K	$40.22M	-
Other	Lyssikatos Joseph P	740.2K	$34.02M	-
10%	Orbimed Advisors LLC	245.7K	$11.29M	-281,408
COO	Patel Anish	215.0K	$9.88M	-

Activity

Buys and sells only

Transactions

10 filings · page 19

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 22, 2022	Leonard Braden Michael60	-	Buy	560,000	$1.40	$783,840.00	+10.9%	-13.2%	+245.5%
Apr 6, 2022	New Enterprise Associates 14, L.P.	10% Owner	Sell	694,551	$1.08	$751,255.76	-11.3%	+3.6%	+378.8%
Feb 23, 2022	Mott David M88	Director	Buy	151,472	$1.45	$219,667.14	+37.9%	-14.5%	+335.9%
Feb 17, 2022	Mott David M88	Director	Buy	45,926	$1.19	$54,673.35	+31.4%	-0.8%	+327.6%
Feb 14, 2022	Mott David M88	Director	Buy	31,826	$1.23	$39,246.16	+99.2%	+3.5%	+382.6%
Jan 25, 2022	New Enterprise Associates 14, L.P.	10% Owner	Sell	134,558	$1.50	$202,208.87	-1.3%	-4.0%	+180.0%
Jan 20, 2022	New Enterprise Associates 14, L.P.	10% Owner	Sell	26,555	$1.83	$48,725.97	-0.3%	-20.9%	+130.5%
Jan 14, 2022	New Enterprise Associates 14, L.P.	10% Owner	Sell	21,550	$1.94	$41,826.49	-0.2%	-46.4%	+130.9%
Jan 11, 2022	New Enterprise Associates 14, L.P.	10% Owner	Sell	18,760	$2.07	$38,739.78	-0.2%	-50.7%	+117.7%
Jan 6, 2022	New Enterprise Associates 14, L.P.	10% Owner	Sell	31,916	$2.26	$72,188.58	-0.3%	-47.9%	+118.6%

← PrevPage 19Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC